Newly approved COVID-19 pills come with a catch. Here’s what you should know
U.S. regulators authorized Pfizer's pill, Paxlovid, and Merck's molnupiravir this week.
View ArticlePfizer’s antiviral COVID-19 pill approved by U.K. regulators
Pfizer this month said Paxlovid showed near 90 per cent efficacy in preventing hospitalizations and deaths in high-risk COVID-19 patients.
View ArticleAstraZeneca COVID-19 drug prevents severe disease if given early, company says
The risk reduction was even better in patients who started therapy within just five days of initial symptoms, said company AstraZeneca.
View ArticleHealth Canada to review AstraZeneca’s COVID-19 prevention drug
AstraZeneca has submitted its COVID-19 prevention drug to Health Canada for approval, which would make it the first antibody protection of its kind in Canada.
View ArticleMerck to make its COVID-19 antiviral pill in Canada, company announces
Merck has reached an agreement with an Ontario pharmaceutical company to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.
View ArticleUBC researchers say nasal spray could be the newest defense against COVID-19
A nasal spray mechanism was found to be the most effective way to administer N-0385, Dr. François Jean said, as the virus tends to enter through the nasal passage.
View ArticleU.S. gives full approval to 1st COVID-19 drug for young children
The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's GILD.O drug remdesivir.
View ArticleCanadian researchers discover ‘weak spot’ in COVID-19 virus key to treatments
Researchers at the University of British Columbia have discovered what they are calling a `` weak spot'' in the virus that causes COVID-19.
View ArticleU.S. to move COVID-19 vaccines, treatments to private market by 2023 once...
President Joe Biden's administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by January, officials said Tuesday.
View ArticleCanada enters 5th year of COVID-19. Are we falling short in treatment?
As Canada enters its fifth year navigating COVID-19, treatment options for the virus remain disappointingly inadequate, according to advocates and experts.
View Article
